Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$25.89 - $29.73 $360,233 - $413,663
13,914 Added 197.39%
20,963 $581,000
Q4 2023

Feb 08, 2024

SELL
$26.13 - $33.94 $426,729 - $554,274
-16,331 Reduced 69.85%
7,049 $202,000
Q3 2023

Nov 14, 2023

SELL
$32.09 - $37.51 $14,697 - $17,179
-458 Reduced 1.92%
23,380 $775,000
Q2 2023

Aug 11, 2023

SELL
$36.12 - $41.79 $129,706 - $150,067
-3,591 Reduced 13.09%
23,838 $874,000
Q1 2023

May 12, 2023

BUY
$39.39 - $51.28 $452,827 - $589,514
11,496 Added 72.15%
27,429 $1.12 Million
Q4 2022

Feb 13, 2023

BUY
$41.75 - $54.5 $68,762 - $89,761
1,647 Added 11.53%
15,933 $816,000
Q3 2022

Nov 14, 2022

SELL
$43.76 - $53.42 $265,929 - $324,633
-6,077 Reduced 29.84%
14,286 $625,000
Q2 2022

Aug 10, 2022

SELL
$46.53 - $55.17 $11,353 - $13,461
-244 Reduced 1.18%
20,363 $1.07 Million
Q1 2022

May 10, 2022

BUY
$45.75 - $56.69 $164,059 - $203,290
3,586 Added 21.07%
20,607 $1.07 Million
Q4 2021

Jan 19, 2022

SELL
$41.32 - $61.25 $89,127 - $132,116
-2,157 Reduced 11.25%
17,021 $1.01 Million
Q3 2021

Nov 12, 2021

BUY
$39.25 - $50.42 $752,736 - $966,954
19,178 New
19,178 $825,000
Q2 2021

Aug 06, 2021

SELL
$35.91 - $40.68 $391,885 - $443,940
-10,913 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$33.49 - $37.77 $167,684 - $189,114
-5,007 Reduced 31.45%
10,913 $395,000
Q4 2020

Feb 16, 2021

SELL
$33.47 - $42.56 $85,448 - $108,655
-2,553 Reduced 13.82%
15,920 $586,000
Q3 2020

Nov 17, 2020

BUY
$31.75 - $37.25 $101,092 - $118,604
3,184 Added 20.83%
18,473 $678,000
Q2 2020

Aug 13, 2020

BUY
$30.12 - $36.54 $460,504 - $558,660
15,289 New
15,289 $500,000
Q3 2019

Nov 08, 2019

SELL
$32.49 - $42.13 $184,705 - $239,509
-5,685 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$36.98 - $41.52 $210,231 - $236,041
5,685 New
5,685 $246,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $162B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Trek Financial, LLC Portfolio

Follow Trek Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trek Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Trek Financial, LLC with notifications on news.